April 9, 2012
SEATTLE, WA. Sage Bionetworks, Mount Sinai School of Medicine (MSSM), University of Pennsylvania (Penn), the National Institute of Mental Health (NIMH), and Takeda Pharmaceuticals Company Limited (TAKEDA) have launched a Public-Private Pre-Competitive Consortium to generate and analyze large-scale genomic data from human subjects with neuropsychiatric disease and to make this data and the associated analytical [...]
NSG Precision Cells Releases New Screw Cap Absorbance Cuvette
April 9, 2012
NSG Precision Cells, a leader in the silicon industry, is pleased to announce their new innovative screw cap absorbance cuvette. With over 50 years’ experience and expertise, NSG Precision Cells is recognized as a frontrunner in advanced quartz technology and quality products. NSG’s absorption cuvette is made from the finest Extrasil (ES) Quartz and handmade [...]
Ironridge BioPharma to Invest $500,000 in Pressure BioSciences
April 9, 2012
SOUTH EASTON, Mass.— Pressure BioSciences, Inc.(“PBI” or the “Company”) today announced that it has entered into a definitive agreement with Ironridge BioPharma Co. (“Ironridge”) to purchase $500,000.00 in shares of Series E Convertible Preferred Stock (the “Preferred Stock”) of the Company. Each share of the 500 shares of Preferred Stock to be sold to Ironridge [...]
Illumina’s Board of Directors Sends Fourth Letter to Stockholders
April 9, 2012
RECOMMENDS STOCKHOLDERS REJECT ROCHE’S OFFER AND VOTE WHITE PROXY CARD SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today is sending a letter from its Board of Directors highlighting supportive reports issued by two of the [...]
Leading Proxy Advisory Firms Issue Reports in Strong Support of Illumina
April 6, 2012
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a leading developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today announced that Institutional Shareholder Services Inc. (“ISS”) considers the Roche offer to acquire Illumina inadequate and has recommended that its clients support the re-election of Illumina’s [...]
Roche disappointed with ISS recommendation
April 6, 2012
Roche released the following statement in response to a report issued by Institutional Shareholder Services (“ISS”) recommending that shareholders of Illumina, Inc. (NASDAQ: ILMN) vote against the election of Roche’s independent director nominees to Illumina’s Board of Directors: “While we are disappointed that ISS has recommended that Illumina shareholders vote against our director nominees at [...]
April 5, 2012
Nano3D BiosciencesTM (n3D), a company that specializes in three-dimensional (3D) cell culturing technology for the drug discovery, toxicology, and life science research markets, announces the release of its 24-well Bio-AssemblerTM. “We are very excited about this product release as it represents a significant milestone for our company from both a scientific and business perspective. The [...]
Waters Selects Ireland’s NIBRT and Prof. Pauline Rudd for Center of Innovation Program Honors
April 5, 2012
Milford, Mass. – At a ceremony officiated by Minister Sean Sherlock TD, Irish Minister for Research and Innovation, Department of Jobs, Enterprise & Innovation, Waters Corporation (NYSE:WAT) welcomed the Irish National Institute for Bioprocessing Research and Training (NIBRT) into its Centers of Innovation Program. Waters acknowledged NIBRT and the research team under the direction of [...]
April 5, 2012
CARLSBAD, Calif.,-- Life Technologies Corporation (NASDAQ: LIFE) today announced that the U.S. Food and Drug Administration has extended its recent method equivalency finding of the Applied Biosystems TaqMan® Salmonella Enteritidis Detection Kit to test poultry eggs for additional use on environmental samples at production houses where the breakfast staple is handled and packaged. The kit [...]
Pressure BioSciences Common Stock to Begin Trading Today on the OTCQB™ Tier of the OTC Marketplace
April 5, 2012
South Easton, MA,– Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that its common stock will begin trading on the OTCQB tier of the OTC Marketplace (“OTCQB”) effective today, Thursday, April 5, 2012. The OTCQB is a market tier for OTCtraded companies that are registered and current in their reporting with the [...]
